{"id":"559355-9981","orgnr":"559355-9981","name":"Prolevi Bio AB","name_registered_on":"2022-02-22","legal_form":{"code":"AB","name":"Aktiebolag"},"status":"registered","registered_on":"2021-12-21","business_description":"Bolaget har till föremål för sin verksamhet att, direkt eller indirekt, bedriva forskning och utveckling, tillverkning, marknadsföring, försäljning och licensiering av läkemedel, samt att bedriva därmed förenlig verksamhet.","industries":[{"code":"72101","name":"Bioteknisk forskning och utveckling"}],"postal_address":{"city":"LUND","country":"SE","municipality":{"code":"1281","name":"Lund"},"county":{"code":"12","name":"Skåne län"}},"registered_office":{"municipality":{"code":"1281","name":"Lund"},"county":{"code":"12","name":"Skåne län"}},"activity_status":"active","employee_class":{"code":"1","name":"0 anställda"},"turnover_class":{"code":"1","name":"1 - 499 tkr","year":2025},"f_tax":"registered","vat":"registered","employer":"registered","registry_source":{"dataset":"bolagsverket_bulkfil","published_on":"2026-11-16"},"annual_reports":[{"from":"2025-01-01","to":"2025-12-31","framework":"K3","signed_on":"2026-06-02","documents":{"annual_report":"/v1/documents/8b30669d-bdef-467d-8ab0-c312985e5c5f.xhtml"},"source":{"dataset":"arsredovisningar","file":"2026/26_14.zip"}}],"latest_financials":{"from":"2025-01-01","to":"2025-12-31","scope":"company","currency":"SEK","net_sales":0,"other_operating_income":58857,"operating_profit":-1186385,"profit_after_financial_items":-1588990,"net_profit":-1588990,"total_assets":8097400,"current_assets":264550,"equity":6187743,"share_capital":36485,"unrestricted_equity":-1685060,"long_term_liabilities":308333,"current_liabilities":1601324,"cash":88876,"staff_costs":134912,"equity_ratio":0.764,"source":{"annual_report":"2025-12-31","document":"/v1/documents/8b30669d-bdef-467d-8ab0-c312985e5c5f.xhtml"},"anchors":{"cash":{"text":"88 876","prefix":"Summa kassa och bank","suffix":"2 566 740"},"current_assets":{"text":"264 550"},"current_liabilities":{"text":"1 601 324"},"equity":{"text":"6 187 743"},"equity_ratio":{"text":"76,4"},"long_term_liabilities":{"text":"308 333","prefix":"skulder"},"net_sales":{"text":"0","prefix":"Nettoomsättning"},"operating_profit":{"text":"1 186 385"},"other_operating_income":{"text":"58 857"},"profit_after_financial_items":{"text":"1 588 990"},"share_capital":{"text":"36 485","prefix":"Utgående balans"},"staff_costs":{"text":"134 912"},"total_assets":{"text":"8 097 400","prefix":"Balansomslutning"},"unrestricted_equity":{"text":"1 685 060","suffix":"Styrelsen"}}},"officers":{"annual_report":"2025-12-31","signed_on":"2026-06-02","signatories":[{"name":"E*****","role":"Styrelseordförande"},{"name":"A*****","role":"Styrelseledamot"},{"name":"K*****","role":"Styrelseledamot"},{"name":"S*****","role":"Verkställande direktör"}]},"group":{"subsidiaries":[{"name":"Prolevi Bio, Inc.","depth":1,"capital_share":1,"source":{"by":"parent","annual_report":"2025-12-31"}}],"list":{"annual_report":"2025-12-31","signed_on":"2026-06-02","completeness":"incomplete","shares_in_group_companies":0,"book_values":35077,"currency":"SEK","listed":1}},"changes":[{"kind":"employee_class","seen":"2026-11-08","from":{"code":"2","name":"1-4 anställda"},"to":{"code":"1","name":"0 anställda"}}]}